-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, May 10, recently, from the State Drug Administration, after review, the "temporary pacemaker" produced by Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
It is reported that the temporary pacemaker of Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
This product is the first domestic temporary cardiac pacemaker.
It can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
It can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
The paclitaxel-eluting PTCA balloon dilatation catheter of Zhejiang Batai Medical Technology Co.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
At present, more and more patients with coronary heart disease are receiving interventional therapy and coronary stents.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
The peripheral nerve sleeve of Beijing Huifukang Medical Technology Co.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
Nerve sleeve cannula products can be sutured to the two broken ends of the nerve through surgical operations (a small gap of 2mm is left between the broken ends of the nerve in the sleeve) to temporarily fix and support the two broken ends of the injured nerve and provide one for the two broken ends of the nerve The relatively closed space helps guide the axial growth of the axons of neurons, and at the same time, it uses the characteristics of selective regeneration of peripheral nerves to effectively promote the accurate docking of nerves, reduce the occurrence of exogenous and neuroma formation, and can replace the traditional extraneural Membrane or perineurium suture method.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
The drug supervision and administration department will strengthen post-market supervision of products to protect the safety of patients using equipment.
(National News)
(National News)
Medical News, May 10, recently, from the State Drug Administration, after review, the "temporary pacemaker" produced by Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
It is reported that the temporary pacemaker of Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
This product is the first domestic temporary cardiac pacemaker.
It can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
It can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
The paclitaxel-eluting PTCA balloon dilatation catheter of Zhejiang Batai Medical Technology Co.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
At present, more and more patients with coronary heart disease are receiving interventional therapy and coronary stents.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
The peripheral nerve sleeve of Beijing Huifukang Medical Technology Co.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
Nerve sleeve cannula products can be sutured to the two broken ends of the nerve through surgical operations (a small gap of 2mm is left between the broken ends of the nerve in the sleeve) to temporarily fix and support the two broken ends of the injured nerve and provide one for the two broken ends of the nerve The relatively closed space helps guide the axial growth of the axons of neurons, and at the same time, it uses the characteristics of selective regeneration of peripheral nerves to effectively promote the accurate docking of nerves, reduce the occurrence of exogenous and neuroma formation, and can replace the traditional extraneural Membrane or perineurium suture method.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
The drug supervision and administration department will strengthen post-market supervision of products to protect the safety of patients using equipment.
(National News)
(National News)
Medical News, May 10, recently, from the State Drug Administration, after review, the "temporary pacemaker" produced by Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
, Ltd.
, Zhejiang Batai Medical Technology Co.
, Ltd.
Three innovative products, "Paclitaxel-eluting PTCA Balloon Dilatation Catheter" and "Peripheral Nerve Sleeve" produced by Beijing Huifukang Medical Technology Co.
, Ltd.
have been approved for listing.
It is reported that the temporary pacemaker of Shenzhen Xianjian Xinkang Medical Electronics Co.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
, Ltd.
consists of a non-implantable pulse generator and a patient cable.
It is suitable for external temporary pacing of the atrium or ventricle, and also suitable for the analysis of the pacing electrode system during the implantation of pacemakers and defibrillators.
This product is the first domestic temporary cardiac pacemaker.
It can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
Heart Heart Heart Hospital Hospital HospitalIt can be used for temporary pacing of patients with bradycardia, and it can also be used as a pacing system analyzer to analyze the pacing system, including impedance measurement and pacing.
Strike threshold and perception amplitude measurement, etc.
The product market may improve hospital efficiency of use of equipment, reduce the cost of hospital equipment, to promote the application of pacing therapy in China.
The paclitaxel-eluting PTCA balloon dilatation catheter of Zhejiang Batai Medical Technology Co.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
, Ltd.
has improved the affinity between the drug and the balloon surface through process improvement and innovation, which is conducive to forming a uniformly distributed drug coating and improving the overall combination of the coating strength.
It is suitable for percutaneous transluminal angioplasty for patients suffering from coronary stent restenosis.
At present, more and more patients with coronary heart disease are receiving interventional therapy and coronary stents.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
However, some patients may experience restenosis in the stent after a period of time.
The paclitaxel-eluting PTCA balloon dilatation catheter is expanded by balloon inflation and mechanically expands the restenosis site.
At the same time, paclitaxel in the drug coating is quickly released to inhibit the proliferation of the vascular intima.
The product is expected to improve the long-term patency rate of target vessels, improve the quality of life of patients, and provide new treatment options for patients with in-stent restenosis.
The peripheral nerve sleeve of Beijing Huifukang Medical Technology Co.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
, Ltd.
is made of chitosan material through acetylation, and is colorless or light yellow translucent tube.
Used for non-pathological nerve injury of the median nerve, ulnar nerve, and radial nerve of the upper limbs (the length of the nerve defect is not more than 2cm), and the end-to-end tension-free socket suture repair of the nerve stump.
Nerve sleeve cannula products can be sutured to the two broken ends of the nerve through surgical operations (a small gap of 2mm is left between the broken ends of the nerve in the sleeve) to temporarily fix and support the two broken ends of the injured nerve and provide one for the two broken ends of the nerve The relatively closed space helps guide the axial growth of the axons of neurons, and at the same time, it uses the characteristics of selective regeneration of peripheral nerves to effectively promote the accurate docking of nerves, reduce the occurrence of exogenous and neuroma formation, and can replace the traditional extraneural Membrane or perineurium suture method.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
In addition, the acetylated chitosan material used in this product can be degraded and absorbed by the human body, and has not been used in nerve repair products already on the market in China.
The drug supervision and administration department will strengthen post-market supervision of products to protect the safety of patients using equipment.
(National News)
Medicine, medicine, medicine (National News)
